NCT02370056

Brief Summary

The anticipated advantages of 3D laparoscopic visualization for the surgeon are greater accuracy and speed in manual skills, translating to decreased operative time, reduced learning curve, and superior safety.We aimed to determine the feasibility of the laparoscopic approach using 3D visualization in the surgical treatment of ulcerative colitis

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
53

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2015

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 9, 2015

Completed
15 days until next milestone

First Posted

Study publicly available on registry

February 24, 2015

Completed
5 days until next milestone

Study Start

First participant enrolled

March 1, 2015

Completed
4.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 17, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 17, 2019

Completed
1.6 years until next milestone

Results Posted

Study results publicly available

December 17, 2020

Completed
Last Updated

May 12, 2021

Status Verified

April 1, 2021

Enrollment Period

4.2 years

First QC Date

February 9, 2015

Results QC Date

November 22, 2020

Last Update Submit

April 14, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Operating Time

    total operating time

    180 minutes

Secondary Outcomes (1)

  • Major Complication

    180 minutes

Study Arms (2)

3D Visualization

EXPERIMENTAL

3-dimensional visualization: In this group, total laparoscopic abdominal colectomy will be performed for patients diagnosed with ulcerative colitis by using 3D Laparoscopic Surgical Video System. This group will be consisted of 27 patients, 9 colectomies performed by 3 surgeons.Effect of using 3D Laparoscopic Surgical Video System on operative outcomes will be evaluated.

Diagnostic Test: 3-dimensional visualization

2D Visualization

ACTIVE COMPARATOR

2-dimensional visualization: In this group, total laparoscopic abdominal colectomy will be performed for patients diagnosed with ulcerative colitis by using conventional Laparoscopic Surgical Video System. This group will be consisted of 27 patients, 9 colectomies performed by 3 surgeons and outcomes will be evaluated.

Diagnostic Test: 2-dimensional visualization

Interventions

Subjects are receiving Standard of Care Colectomy for Ulcerative Colitis visualized in 3D mode

3D Visualization

Subjects are receiving Standard of Care Colectomy for Ulcerative Colitis visualized in 2D mode

2D Visualization

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Indication for surgery must be Ulcerative Colitis
  • Patient age between 18 and 80
  • Elective procedure
  • BMI between 17 and 30
  • Total colectomy with end ileostomy, without proctectomy

You may not qualify if:

  • Any preoperative diagnosis other than UC
  • Patient age\< 18, or \>80
  • Emergency surgery
  • Previous gastrointestinal surgery
  • BMI\>30
  • Pregnancy
  • Presence of any gastrointestinal tract malignancy
  • Segmental colon resections, completion proctectomy, total proctocolectomy, pouch procedures

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cleveland Clinic

Cleveland, Ohio, 44195, United States

Location

MeSH Terms

Conditions

Colitis, Ulcerative

Condition Hierarchy (Ancestors)

ColitisGastroenteritisGastrointestinal DiseasesDigestive System DiseasesInflammatory Bowel DiseasesColonic DiseasesIntestinal Diseases

Results Point of Contact

Title
Dr. Emre Gorgun
Organization
Cleveland Clinic

Study Officials

  • Emre Gorgun, MD

    The Cleveland Clinic

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD

Study Record Dates

First Submitted

February 9, 2015

First Posted

February 24, 2015

Study Start

March 1, 2015

Primary Completion

May 17, 2019

Study Completion

May 17, 2019

Last Updated

May 12, 2021

Results First Posted

December 17, 2020

Record last verified: 2021-04

Data Sharing

IPD Sharing
Will not share

Locations